Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HAL SREDEN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1467555789
CMS profile
157542
Location
BRUNSWICK, ME

General Payments · PY2018–2024

$4,239.77

  • Reported across 136 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,279.94

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $651.84 2
Food and Beverage $628.10 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $24.84 1
PY2019 $767.37 9
PY2020 $946.65 34
PY2021 $386.46 22
PY2022 $332.77 13
PY2023 $501.74 21
PY2024 $1,279.94 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.02 10/02/2024 Food and Beverage Undisputed 01/23/2026 1106150295 CMS
AstraZeneca Pharmaceuticals LP $16.88 05/01/2024 Food and Beverage Undisputed 01/23/2026 1105620101 CMS
Ethicon Inc. $39.18 09/04/2024 Food and Beverage Undisputed 01/23/2026 1077583418 CMS
GENZYME CORPORATION $17.16 07/09/2024 Food and Beverage Undisputed 01/23/2026 1139951429 CMS
GlaxoSmithKline, LLC. $18.58 02/26/2024 Food and Beverage Undisputed 01/23/2026 1116677053 CMS
GlaxoSmithKline, LLC. $19.18 03/13/2024 Food and Beverage Undisputed 01/23/2026 1116725660 CMS
GlaxoSmithKline, LLC. $17.40 03/29/2024 Food and Beverage Undisputed 01/23/2026 1116675765 CMS
GlaxoSmithKline, LLC. $20.80 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116539833 CMS
GlaxoSmithKline, LLC. $4.24 04/23/2024 Food and Beverage Undisputed 01/23/2026 1115765743 CMS
GlaxoSmithKline, LLC. $6.90 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116287792 CMS
GlaxoSmithKline, LLC. $5.35 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116433750 CMS
GlaxoSmithKline, LLC. $18.77 05/30/2024 Food and Beverage Undisputed 01/23/2026 1116421829 CMS
GlaxoSmithKline, LLC. $9.65 06/10/2024 Food and Beverage Undisputed 01/23/2026 1116205628 CMS
GlaxoSmithKline, LLC. $6.10 07/15/2024 Food and Beverage Undisputed 01/23/2026 1116263761 CMS
GlaxoSmithKline, LLC. $29.08 07/18/2024 Food and Beverage Undisputed 01/23/2026 1115873146 CMS
GlaxoSmithKline, LLC. $6.25 08/14/2024 Food and Beverage Undisputed 01/23/2026 1116600487 CMS
GlaxoSmithKline, LLC. $14.86 08/27/2024 Food and Beverage Undisputed 01/23/2026 1116306309 CMS
GlaxoSmithKline, LLC. $22.27 09/02/2024 Food and Beverage Undisputed 01/23/2026 1116572887 CMS
GlaxoSmithKline, LLC. $3.95 09/04/2024 Food and Beverage Undisputed 01/23/2026 1115828477 CMS
GlaxoSmithKline, LLC. $8.05 10/21/2024 Food and Beverage Undisputed 01/23/2026 1116381048 CMS
Insmed, Inc. $17.07 10/10/2024 Food and Beverage Undisputed 01/23/2026 1089559592 CMS
La Jolla Pharmaceutical Company $22.42 04/23/2024 Food and Beverage Undisputed 01/23/2026 1154251338 CMS
Masimo Corporation $25.80 06/03/2024 Food and Beverage Undisputed 01/23/2026 1152317031 CMS
Merck Sharp & Dohme LLC $15.23 08/20/2024 Food and Beverage Undisputed 01/23/2026 1141864109 CMS
Mylan Specialty L.P. $33.08 08/26/2024 Food and Beverage Undisputed 01/23/2026 1147300713 CMS
Mylan Specialty L.P. $27.47 09/30/2024 Food and Beverage Undisputed 01/23/2026 1147314496 CMS
Olympus Corporation of the Americas $616.84 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1110439442 CMS
Olympus Corporation of the Americas $35.00 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1110439444 CMS
Olympus Corporation of the Americas $53.79 09/05/2024 Food and Beverage Undisputed 01/23/2026 1110439446 CMS
Regeneron Healthcare Solutions, Inc. $19.43 11/12/2024 Food and Beverage Undisputed 01/23/2026 1114191121 CMS
Siemens Medical Solutions USA, Inc. $14.15 04/26/2024 Food and Beverage Undisputed 01/23/2026 1093685450 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.50 02/06/2024 Food and Beverage Undisputed 01/23/2026 1137680935 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.14 04/22/2024 Food and Beverage Undisputed 01/23/2026 1137680937 CMS
United Therapeutics Corporation $18.59 07/10/2024 Food and Beverage Undisputed 01/23/2026 1149444396 CMS
United Therapeutics Corporation $17.24 12/02/2024 Food and Beverage Undisputed 01/23/2026 1149444814 CMS
Vifor Pharma, Inc. $26.52 09/25/2024 Food and Beverage Undisputed 01/23/2026 1124063718 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.